Page last updated: 2024-10-25

cilostazol and Metabolic Syndrome

cilostazol has been researched along with Metabolic Syndrome in 2 studies

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research Excerpts

ExcerptRelevanceReference
" We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents."4.82The top 12 advances in vascular medicine. ( Beckman, JA; Jaff, MR; Jang, J; Olin, JW; Rooke, T, 2004)
"The key areas of treatment focus on smoking cessation, exercise rehabilitation, with supervised therapy if possible, cardiovascular risk prevention with antiplatelet drugs, statins and angiotensin converting enzymes, and correction of atherosclerotic risk factors with well-defined targets (LDL less than 1g/L, HDL greater than 0."2.45[Peripheral arterial disease with lower limb claudication: Medical treatment]. ( Bui, HT; Hadj Henni, A; Journet, J; Long, A, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Long, A1
Bui, HT1
Journet, J1
Hadj Henni, A1
Olin, JW1
Jang, J1
Jaff, MR1
Beckman, JA1
Rooke, T1

Reviews

2 reviews available for cilostazol and Metabolic Syndrome

ArticleYear
[Peripheral arterial disease with lower limb claudication: Medical treatment].
    Journal des maladies vasculaires, 2009, Volume: 34, Issue:5

    Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Cilostazol; Comorbidity; Diabetes Complications; Dr

2009
The top 12 advances in vascular medicine.
    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2004, Volume: 11 Suppl 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Clopidogrel; Factor V; Heparin, Low-Molecular-

2004